Carbowemb 150mg Injection
Marketer
Wembrace Biopharma Pvt. Ltd.
Salt Composition
Carboplatin (10mg/ml)
Overview Carbowemb 150mg Injection
Oncaspar 150mg Injection is indicated for ovarian and small cell lung cancers. Its mechanism involves inhibiting or retarding cancerous cell proliferation. Administered intravenously under medical supervision, the dosage and frequency are determined by your physician based on your condition and may be adjusted. Adhere strictly to the prescribed regimen; incorrect usage or overdose can lead to severe adverse effects. Therapeutic benefits may not be immediately apparent, requiring several weeks or months; discontinue only upon medical advice. Typical side effects include nausea, vomiting, tiredness, and elevated liver enzymes. This injection can decrease blood cell counts (red and white), increasing infection or bleeding risks. Report fever, sore throat, chills, unusual bleeding/bruising, or dark urine immediately. Regular blood tests monitoring blood cell levels, along with heart, liver function, and uric acid, are essential. Report any allergic reactions like skin rash, itching, or respiratory distress. Inform your healthcare provider of all other medications you are taking due to potential interactions. This injection is contraindicated during pregnancy or breastfeeding. Reliable contraception is crucial for both partners throughout treatment to prevent pregnancy.
Uses of Carbowemb 150mg Injection
Cancers of the ovary and small-cell lung
Major Benefits of Carbowemb 150mg Injection:
This medication will be administered by your physician or their designated nurse; self-medication is strictly prohibited.
Common Side effects of Carbowemb 150mg Injection:
- Nausea
- Vomiting
- Anemia (low number of red blood cells)
- Fatigue
- Low blood platelets
- Increased liver enzymes
- Decreased white blood cell count (neutrophils)
- Stomatitis (Inflammation of the mouth)
- Peripheral neuropathy (tingling and numbness of feet and hand)
- Diarrhea
How to use Carbowemb 150mg Injection:
This medication will be administered by your healthcare provider. Self-medication is strictly prohibited.
How Carbowemb 150mg Injection works:
Carbowemb 150mg Injection is an anticancer agent that disrupts the genetic makeup (DNA and RNA) of cancerous cells, thereby inhibiting their proliferation and growth.
SAFETY ADVICE
AlcoholCONSULT YOUR DOCTOR
Alcohol consumption alongside Carbowemb 150mg Injection may pose unknown risks. Seek medical advice before combining them.
PregnancyCONSULT YOUR DOCTOR
Administering Carbowemb 150mg Injection during pregnancy poses a confirmed risk to fetal development and is therefore contraindicated. In exceptional circumstances involving life-threatening conditions, a physician might prescribe it if the potential benefits outweigh the known hazards. Physician consultation is essential.
Breast feedingUNSAFE
Administration of Carbowemb 150mg Injection is contraindicated while breastfeeding due to potential infant toxicity.
DrivingUNSAFE
Administering Carbowemb 150mg Injection can lead to reduced awareness, visual disturbances, drowsiness, and dizziness. Driving should be avoided if any of these effects are experienced.
KidneyCAUTION
Exercise caution when administering Carbowemb 150mg Injection to individuals with impaired renal function; dosage modification may be necessary. Consult a physician. Carbowemb 150mg Injection is contraindicated in patients exhibiting severe kidney disease. Routine monitoring of kidney function is recommended during treatment.
LiverSAFE IF PRESCRIBED
The use of Carbowemb 150mg Injection in individuals with hepatic impairment is likely safe. Existing evidence indicates dose modification may be unnecessary; however, medical advice is recommended.
What if you forget to take Carbowemb 150mg Injection :
Should you forget a scheduled Carbowemb 150mg Injection, seek medical advice.
Facts to Know About Carbowemb 150mg Injection
Label | Value |
---|---|
Chemical Category | Platinum Equivalents |
Developing Habits | No. |
Treatment Category | Cancer Medications |
Actions | Platinum-based Anticancer Agents |